References
1. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.J Immunol. 1991;146:1410-1415.
2. Metcalfe DD. Classification and diagnosis of mastocytosis: Current status. J Invest Dermatol. 1991;96:2S-4S.
3. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA.1995;92:10560-10564.
4. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with ”idiopathic” anaphylaxis. Blood. 2007;110(7):2331-2333.
5. Kim DK, Cho YE, Komarow HD, et al. Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activation. Proc Natl Acad Sci U S A.2018;115(45):E10692-E10701.
6. Boyden SE, Desai A, Cruse G, et al. Vibratory Urticaria Associated with a Missense Variant in ADGRE2. N Engl J Med.2016;374(7):656-663.